G1 Therapeutics Stock Predictions

Healthcare > Biotechnology

Buy GTHX

*Your capital is at risk

$7.15

+0 (+0%)

At Close: Dec 16, 2024

Currently predicting for Fri, 12 Jun 2026

GTHX Live board

Community Bull/Bear

Target Next close

Join the GTHX prediction battle

Create a free account to see the full board, submit your call, compare with other predictors, and build a public record.

Create free account Log in

GTHX Prediction Chart

Unlock the prediction chart

Registered users can inspect target prices, community averages, and how calls develop across recent sessions.

Create free account Log in

Forecast Desk

3-Month Forecasts For GTHX

Forecasts map a 66-session price path from approved predictors. Log in or create a free account to view forecasts and request one for this ticker.

Create free account Log in to view forecasts

GTHX Predictions History

Predictor	Target Session	Target Price	Accuracy
Community predictor	Next session	USD target	Record locked
Ranked predictor	Previous session	Bullish/Bearish	Score locked

See the prediction record

Create free account Log in

Forecast Desk

Request A 3-Month Forecast

Price path
Approved predictor
3-month horizon

Create Free Account Log In To View Forecasts

ABOUT G1 THERAPEUTICS INC

G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/etoposide-containing regimen or topotecan-containing regimen for extensive stage small cell lung cancer...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
EAT $140.46	13.01%	Jun 05
TPR $140.47	3.50%	Jun 04
GLBE $31.61	5.09%	May 05
FIZZ $34.11	8.36%	May 01
W WCLD $27.34	12.18%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by